Non-invasive Left Ventricle Contractility dp/dt as Prognostic Marker in Chest Unit Patients
dp/dt
Non Invasive Left Ventricle Contractility dp/dt Could be Used as a Prognostic Marker in Patients Admitted to the Emergency Department for Chest Pain
1 other identifier
observational
500
1 country
1
Brief Summary
Ischemic heart disease is a major public health problem with high mortality rate despite the progress in management and the resources mobilized. The idea is that myocardial ischemia is generally associated with left ventricular dysfunction and, consequently, a possible alteration of the dp/dt index. As dp/dt could be assessed non-invasively by plethysmographic method, it is interesting to investigate its prognostic performance in patients with indifferentiate chest pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2022
CompletedFirst Submitted
Initial submission to the registry
June 8, 2022
CompletedFirst Posted
Study publicly available on registry
June 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedMay 16, 2023
May 1, 2023
12 months
June 8, 2022
May 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
MACE
the occurrence of a major cardiovascular event (MACE)
one month
MACE
: the occurrence of a major cardiovascular event (MACE)
SIX MONTHS
Eligibility Criteria
patients presenting to the emergency department with acute chest pain
You may qualify if:
- age over 18 years old,
- acute chest pain
You may not qualify if:
- traumatic chest pain,
- hemodynamic instability;
- arrhythmias;
- holders of a pacemaker;
- STEMI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emergency Departement
Monastir, 5000, Tunisia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nouira Semir, professor
Monastir University Hospital, Monastir, Tunisia, 5000
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 8 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PROFESSOR
Study Record Dates
First Submitted
June 8, 2022
First Posted
June 13, 2022
Study Start
June 1, 2022
Primary Completion
May 31, 2023
Study Completion
September 30, 2023
Last Updated
May 16, 2023
Record last verified: 2023-05